UniProt ID | RHOA_MOUSE | |
---|---|---|
UniProt AC | Q9QUI0 | |
Protein Name | Transforming protein RhoA | |
Gene Name | Rhoa | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 193 | |
Subcellular Localization |
Cell membrane Lipid-anchor Cytoplasmic side. Cytoplasm, cytoskeleton. Cleavage furrow. Cytoplasm, cell cortex. Midbody. Cell projection, lamellipodium . Translocates to the equatorial region before furrow formation in a ECT2-dependent manner. Local |
|
Protein Description | Regulates a signal transduction pathway linking plasma membrane receptors to the assembly of focal adhesions and actin stress fibers. Involved in a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Plays an essential role in cleavage furrow formation. May be an activator of PLCE1. Activated by ARHGEF2, which promotes the exchange of GDP for GTP. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization (By similarity). Required for the apical junction formation of keratinocyte cell-cell adhesion. Regulates KCNA2 potassium channel activity by reducing its location at the cell surface in response to CHRM1 activation; promotes KCNA2 endocytosis. [PubMed: 9635436] | |
Protein Sequence | MAAIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVKPEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQARRGKKKSGCLIL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
16 | S-nitrosocysteine | VIVGDGACGKTCLLI EEECCCCCCCEEEEE | 7.60 | - | |
16 | S-palmitoylation | VIVGDGACGKTCLLI EEECCCCCCCEEEEE | 7.60 | 28526873 | |
16 | S-nitrosylation | VIVGDGACGKTCLLI EEECCCCCCCEEEEE | 7.60 | 21278135 | |
19 | Phosphorylation | GDGACGKTCLLIVFS CCCCCCCEEEEEEEE | 8.15 | 17203969 | |
26 | Phosphorylation | TCLLIVFSKDQFPEV EEEEEEEECCCCCCE | 25.16 | 17203969 | |
34 | Phosphorylation | KDQFPEVYVPTVFEN CCCCCCEECCCEECC | 10.07 | 29514104 | |
42 | Phosphorylation | VPTVFENYVADIEVD CCCEECCEEEEEEEC | 6.99 | - | |
63 | Serotonylation | ALWDTAGQEDYDRLR EEEECCCCCCHHHCC | 37.61 | 14697203 | |
66 | Phosphorylation | DTAGQEDYDRLRPLS ECCCCCCHHHCCCCC | 11.38 | 25159016 | |
104 | Ubiquitination | EKWTPEVKHFCPNVP CCCCHHHHHHCCCCC | 29.33 | - | |
107 | S-palmitoylation | TPEVKHFCPNVPIIL CHHHHHHCCCCCEEE | 2.10 | 28526873 | |
107 | S-nitrosylation | TPEVKHFCPNVPIIL CHHHHHHCCCCCEEE | 2.10 | 21278135 | |
107 | S-nitrosocysteine | TPEVKHFCPNVPIIL CHHHHHHCCCCCEEE | 2.10 | - | |
118 | Ubiquitination | PIILVGNKKDLRNDE CEEEECCHHHHCCCH | 41.56 | - | |
119 | Ubiquitination | IILVGNKKDLRNDEH EEEECCHHHHCCCHH | 67.03 | - | |
135 | Malonylation | RRELAKMKQEPVKPE HHHHHHHHCCCCCCH | 51.29 | 26320211 | |
135 | Acetylation | RRELAKMKQEPVKPE HHHHHHHHCCCCCCH | 51.29 | 22826441 | |
135 | Ubiquitination | RRELAKMKQEPVKPE HHHHHHHHCCCCCCH | 51.29 | - | |
156 | Phosphorylation | NRIGAFGYMECSAKT HHHCCCEEEECCCCC | 5.36 | - | |
159 | S-nitrosocysteine | GAFGYMECSAKTKDG CCCEEEECCCCCCCH | 2.46 | - | |
159 | S-nitrosylation | GAFGYMECSAKTKDG CCCEEEECCCCCCCH | 2.46 | 21278135 | |
159 | S-palmitoylation | GAFGYMECSAKTKDG CCCEEEECCCCCCCH | 2.46 | 28526873 | |
162 | Ubiquitination | GYMECSAKTKDGVRE EEEECCCCCCCHHHH | 39.55 | - | |
188 | Phosphorylation | ARRGKKKSGCLIL-- HHCCCCCCCCEEC-- | 43.55 | 15102857 | |
190 | Geranylgeranylation | RGKKKSGCLIL---- CCCCCCCCEEC---- | 2.49 | - | |
190 | Methylation | RGKKKSGCLIL---- CCCCCCCCEEC---- | 2.49 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
26 | S | Phosphorylation | Kinase | STK24 | Q99KH8 | GPS |
42 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
188 | S | Phosphorylation | Kinase | PKG1 | P0C605 | PSP |
188 | S | Phosphorylation | Kinase | CHAK1 | Q96QT4 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | Kctd13 | Q8BGV7 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | Smurf1 | Q9CUN6 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | Tnfaip1 | O70479 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
188 | S | Phosphorylation |
| - |
188 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RHOA_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RHOA_HUMAN | RHOA | physical | 20360068 | |
SMUF1_HUMAN | SMURF1 | physical | 15710384 | |
PKHG5_MOUSE | Plekhg5 | physical | 16467373 | |
SRGP1_MOUSE | Srgap1 | physical | 11672528 | |
RGRF1_MOUSE | Rasgrf1 | physical | 17993462 | |
CTND1_MOUSE | Ctnnd1 | physical | 17993462 | |
C4BPA_HUMAN | C4BPA | physical | 26496610 | |
CLK2_HUMAN | CLK2 | physical | 26496610 | |
GLGB_HUMAN | GBE1 | physical | 26496610 | |
PEPL_HUMAN | PPL | physical | 26496610 | |
MKNK1_HUMAN | MKNK1 | physical | 26496610 | |
PAPS1_HUMAN | PAPSS1 | physical | 26496610 | |
COX5A_HUMAN | COX5A | physical | 26496610 | |
Z518A_HUMAN | ZNF518A | physical | 26496610 | |
TRI16_HUMAN | TRIM16 | physical | 26496610 | |
TXN4A_HUMAN | TXNL4A | physical | 26496610 | |
POLK_HUMAN | POLK | physical | 26496610 | |
F208B_HUMAN | FAM208B | physical | 26496610 | |
GPAM1_HUMAN | GPALPP1 | physical | 26496610 | |
FGD6_HUMAN | FGD6 | physical | 26496610 | |
SYRM_HUMAN | RARS2 | physical | 26496610 | |
SCYL1_HUMAN | SCYL1 | physical | 26496610 | |
GPBP1_HUMAN | GPBP1 | physical | 26496610 | |
CORO7_HUMAN | CORO7 | physical | 26496610 | |
COG7_HUMAN | COG7 | physical | 26496610 | |
PDE12_HUMAN | PDE12 | physical | 26496610 | |
KPRP_HUMAN | KPRP | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...